Investors

Our Investors

To achieve our ambitious strategy to become a leading biotech company in the development of single-strain keystone biotherapies, we are open to welcome new investors.

Established in 2010, YSOPIA Bioscience has already raised €22.7M.

> Discover our pipeline

Key facts:

We are backed by renowned and valuable investors.

Seventure Partners / Health For Life Capital, Europe’s leading microbiome innovation investment fund, is our historic lead investor.

Three family offices have also backed YSOPIA Bioscience, as well as public investors, including the Nouvelle Aquitaine region. We also received support from BPI France.

Want to talk to our CEO?

Microbiome & us
News
Jul 6, 2021
YSOPIA Successfully Completes Phase 1 Clinical Study of Xla1 Biotherapy for the Treatment of Obesity and Metabolic...
> more
Jun 1, 2021
90 seconds to learn more about YSOPIA Bioscience | [video width="1080" height="1080"...
> more
Press / Media
Sep 13, 2021
The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) apply an aligned and complimentary...
> more
Jun 16, 2021
Forte de la découverte de Christensenella, une bactérie naturellement présente dans les microbiotes sains, la...
> more
Publications
Sep 1, 2021
Héloïse Tudela, Sandrine P. Claus and Maya Saleh Access the full paper The community of the diverse microorganisms...
> more
Aug 11, 2021
Jeanne-Céleste Paquet, Sandrine P. Claus, Magali Cordaillat-Simmons, Wilfrid Mazier, Georges Rawadi, Laure Rinaldi,...
> more
now on twitter
YSOPIA Bioscience

A new review article published in the journal JAMA Psychiatry is suggesting a number of different psychiatric disor… t.co/deSy0oKRFj

YSOPIA Bioscience © 2021 - all rights reserved terms and conditions